Nasdaq Investment Intelligence Content Hub PXI Pertinent, Potent Play on Rising Oil Prices By Tom LydonFebruary 7, 2022
Nasdaq Investment Intelligence Content Hub Innovations in Robotics, AI Will Continue to Power This ETF By Ben HernandezFebruary 4, 2022
Nasdaq Investment Intelligence Content Hub Build Off Growth in Healthcare Innovation With BTEC By Ben HernandezFebruary 3, 2022
Nasdaq Investment Intelligence Content Hub After Slide, Some Chip Stocks Are Worth Revisiting By Tom LydonFebruary 2, 2022
Nasdaq Investment Intelligence Content Hub Cloud Computing M&A Could Heat Up, Lifting This ETF By Tom LydonJanuary 31, 2022
Nasdaq Investment Intelligence Content Hub Investigate Innovators With QQQJ By Tom LydonJanuary 27, 2022
Nasdaq Investment Intelligence Content Hub Traders Are Betting on a Quick Turnaround in Tech ETFs By Max ChenJanuary 26, 2022
Nasdaq Investment Intelligence Content Hub Rising Rates Not Necessarily End of World for Tech Stocks, ETFs By Tom LydonJanuary 26, 2022
Nasdaq Investment Intelligence Content Hub Cap-Weighting Crucial When Indexing Biotech By James ComtoisJanuary 25, 2022
Nasdaq Investment Intelligence Content Hub Sell-Off Could Bring Opportunity in Nasdaq ETFs By Tom LydonJanuary 24, 2022
Nasdaq Investment Intelligence Content Hub This ETF Could Come of Age in 2022 By Tom LydonJanuary 21, 2022
Nasdaq Investment Intelligence Content Hub Find Shelter From Weak Markets With FXG By Tom LydonJanuary 20, 2022
Nasdaq Investment Intelligence Content Hub Multi-Asset Funds Target Steady, Consistent Income for Retirees By James ComtoisJanuary 18, 2022
Nasdaq Investment Intelligence Content Hub Looking at the Nasdaq ETFs as a Contrarian Play By Max ChenJanuary 14, 2022
Nasdaq Investment Intelligence Content Hub Retail Sales Drop in December, But Economists Say: Don’t Panic By James ComtoisJanuary 14, 2022
Nasdaq Investment Intelligence Content Hub Biotech Firms Partner to Advance Therapeutic Medicine By James ComtoisJanuary 13, 2022
Nasdaq Investment Intelligence Content Hub Leveraged Fund Rakes in Record Capital During Market Dip By James ComtoisJanuary 12, 2022
Nasdaq Investment Intelligence Content Hub PKW Pertinent as Buybacks Projected to Soar By Tom LydonJanuary 12, 2022
Nasdaq Investment Intelligence Content Hub Biotech Stocks and ETFs Can Get Their Grooves Back By Tom LydonJanuary 11, 2022
Nasdaq Investment Intelligence Content Hub Dividend Renaissance Perfect for PFM By Tom LydonJanuary 7, 2022
